|
|
|
|
pmid:28259984
|
|
|
|
|
pmid:28257738
|
|
|
|
|
pmid:28253591
|
Shetelig C et al. |
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. |
2017 |
PLoS ONE |
pmid:28253327
|
|
|
|
|
pmid:28252575
|
|
|
|
|
pmid:28249772
|
Lu LY et al. |
Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. |
2017 |
J. Orthop. Res. |
pmid:28248001
|
Irtyuga O et al. |
NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. |
2017 |
Biomed Res Int |
pmid:28246602
|
|
|
|
|
pmid:28244588
|
|
|
|
|
pmid:28244247
|
Hanmoto T et al. |
Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. |
2017 |
Biomed. Res. |
pmid:28239034
|
Fioramonti M et al. |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. |
2017 |
Oncotarget |
pmid:28223547
|
|
|
|
|
pmid:28214531
|
Xiong L et al. |
Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
2017 |
J. Cell Biol. |
pmid:28193701
|
|
|
|
|
pmid:28189120
|
Fortner RT et al. |
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. |
2017 |
BMC Med |
pmid:28173834
|
|
|
|
|
pmid:28165889
|
Kuroyanagi G et al. |
(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. |
2017 |
Prostaglandins Other Lipid Mediat. |
pmid:28163121
|
|
|
|
|
pmid:28161839
|
|
|
|
|
pmid:28153008
|